Charles River Launches HemaCare Donor App to Engage Diverse Donors and Source Cell Solutions for Critical Cell and Gene Therapy Research
yahoo.com
news
2022-10-19 12:00:00

Company aligns HemaCare Donor Center brand to streamline donor experience

WILMINGTON, Mass., October 19, 2022--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE:CRL) today announced the launch of a new digital donor experience to enhance access to its donor centers in four distinct US geographic markets. Charles River has been a trusted cell products and services provider for leading developers of cutting-edge cell therapies and basic research for more than 40 years through its acquisitions of HemaCare and Cellero (formerly Key Biologics and Astarte Biologics), now formally integrated as Charles River Cell Solutions.
